The Current Ratio as of December 2024 (TTM) for Galmed Pharmaceuticals Ltd. (GLMD) is 7.03

According to Galmed Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 7.03. This represents a change of 14.07% compared to the average of 6.17 of the last 4 quarters.

Galmed Pharmaceuticals Ltd. (GLMD) Historical Current Ratio (quarterly & annually)

How has GLMD Current Ratio performed in the past?

The mean historical Current Ratio of Galmed Pharmaceuticals Ltd. over the last ten years is 11.30. The current 7.03 Current Ratio has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), GLMD's Current Ratio was at its highest in in the September 2018 quarter at 43.29. The Current Ratio was at its lowest in in the June 2017 quarter at 2.59.

Galmed Pharmaceuticals Ltd. (GLMD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Galmed Pharmaceuticals Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Galmed Pharmaceuticals Ltd. (GLMD) Average Current Ratio

How has GLMD Current Ratio performed in the past?

The current Current Ratio of Galmed Pharmaceuticals Ltd. (GLMD) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Galmed Pharmaceuticals Ltd. (GLMD) Current Ratio vs. Peers

How is GLMD’s Current Ratio compared to its peers?

Galmed Pharmaceuticals Ltd.’s Current Ratio is less than Affimed N.V. (0), greater than Abeona Therapeutics Inc. (1.93), greater than Akebia Therapeutics, Inc. (6.12), greater than Kodiak Sciences Inc. (1.52), less than Mereo BioPharma Group plc (8.42), greater than Adverum Biotechnologies, Inc. (6.10), greater than Adaptimmune Therapeutics plc (5.82), greater than Pieris Pharmaceuticals, Inc. (3.85), greater than PDS Biotechnology Corporation (4.82), greater than Leap Therapeutics, Inc. (2.84), greater than Fortress Biotech, Inc. (3.97), greater than Mustang Bio, Inc. (1.23), greater than Achilles Therapeutics plc (0.40), greater than Aptose Biosciences Inc. (6.04), greater than Fortress Biotech, Inc. (1.05), greater than null (1.23),

Build a custom stock screener for Galmed Pharmaceuticals Ltd. (GLMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galmed Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galmed Pharmaceuticals Ltd. (GLMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galmed Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.